about
The role of neck dissection in squamous cell carcinoma of the head and neck.The development and validation of oral cancer staging using administrative health data.Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.Keratin 8 expression in head and neck epithelia.Expression of MYSM1 is associated with tumor progression in colorectal cancer.The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosisIncreased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patientsSerum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinomaResults of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality.Expression levels of B7-H3 and TLT-2 in human oral squamous cell carcinoma.Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma.Squamous cell carcinoma of the gingiva: A diagnostic enigma.Higher heat shock factor 1 expression in tumor stroma predicts poor prognosis in esophageal squamous cell carcinoma patientsRole of infectious agents in the carcinogenesis of brain and head and neck cancers.The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma.Association between infection of virulence cagA gene Helicobacter pylori and laryngeal squamous cell carcinomaUpregulation of CENP-H in tongue cancer correlates with poor prognosis and progressionThe expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa.Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.Expression of CTLA-4 and Foxp3 in peripheral blood T cells of patients with squamous cell laryngeal carcinoma.Diagnostic impact of promoter methylation and E-cadherin gene and protein expression levels in laryngeal carcinoma.Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis.Survivorship Challenges and Information Needs after Radiotherapy for Oral Cancer.MMP7 is a target of the tumour-associated antigen EpCAM.Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.Clinical significance of epigenetic silencing and re-expression of O6-methylguanine-DNA methyltransferase using epigenetic agents in laryngeal carcinoma.Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma.Treatment results for ethmoid sinus carcinoma.Identifying risk factors for postoperative cardiovascular and respiratory complications after major oral cancer surgery.Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.AdOnco: a database for clinical and scientific documentation of head and neck oncology.Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.A Predictive Model to Determine the Pattern of Nodal Metastasis in Oral Squamous Cell Carcinoma.The problem of nodal disease in squamous cell carcinoma of the temporal bone
P2860
Q30366869-CE5F8387-24D5-49F6-945A-4A4224A9E2CEQ30828104-96D77870-3D37-4B4D-B0B6-69A0D23ABCEFQ31096247-448781B7-8F0D-4269-A393-D16E02D5EE7FQ33370722-F23C8670-8A08-4731-B801-BF25445EB60FQ33675074-4C1ED47C-D409-4379-A801-6BDEF9B323DFQ33745941-7AAC2A7B-07A8-45B8-9BA3-EE6AF453F789Q34029008-53252F17-2176-4B61-9D53-E989CAE3DD2FQ35053419-B81EC045-FF3E-47E6-A673-B374633B28ECQ35076845-093A9A3C-3064-4569-A9FD-10DB46B3C74EQ35871253-4EEF7968-6F74-4338-B2D5-012BB87AD517Q35909900-153D9FB2-FABC-4FD0-B1EB-8799578BA385Q36180217-06B70C28-B611-4908-B668-1202FF2EF974Q36223509-A9590F2A-5374-481B-B637-382F3538B22BQ36614198-20D175FA-5E02-42E9-9917-42B95934F396Q36758659-09843449-953D-41FA-AA42-C8B8FE0F3A5DQ37033568-A71FAE9F-4E6D-4FDF-BD0D-5FBB9DF1E512Q37251597-E84CD592-1064-4A89-BFA3-4FC8495E1FB0Q37452127-AA2FFD5A-249E-4D4B-ADE7-C224E7C73628Q37574813-9588E3D5-411F-4882-A461-CF177BB7855BQ37601910-93343AB6-598B-4852-BECB-0D23C89C6352Q37601968-D109C172-6C9F-4F6E-B463-440B0A3EE2A4Q38751078-913E9D0D-A78B-4098-B02A-ECD12755D996Q38865595-C2E87010-F4B9-42EC-9956-A0F2907CE878Q39279697-86AF248F-E5A6-4322-8370-585ADDFA6BE8Q39409341-AC17BFB1-F166-4575-AEA3-82A584099DB2Q41751900-7C91128E-A9CD-4145-9C3E-DE91267194F6Q42959413-15785F7C-F381-4191-AD4D-D81799C2CA92Q44418286-112B238B-C88B-4363-80D6-7E33928FB751Q44621214-753D3ADA-0489-4BCF-87A3-AA9D4AFED766Q47429122-1F30D28C-001F-4E42-85A7-921DCECDCF45Q51947955-48ED9B3F-18F0-4257-AB1B-B85FA448F853Q54298531-C26E9CCF-EEFA-4329-BC7B-F30FEFC81F01Q54390286-5C5C6AA1-B124-45BA-815C-17023EDD4FD3Q54957614-C0133639-EFCD-42C2-90D1-0E47A71E8A81Q58284848-F925443E-158A-4164-8558-C1F482ED5D43
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
New TNM staging criteria for head and neck tumors.
@ast
New TNM staging criteria for head and neck tumors.
@en
type
label
New TNM staging criteria for head and neck tumors.
@ast
New TNM staging criteria for head and neck tumors.
@en
prefLabel
New TNM staging criteria for head and neck tumors.
@ast
New TNM staging criteria for head and neck tumors.
@en
P356
P1476
New TNM staging criteria for head and neck tumors.
@en
P2093
Brian O'Sullivan
Jatin Shah
P356
10.1002/SSU.10019
P577
2003-01-01T00:00:00Z